Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 6, Pages 652
Publisher
MDPI AG
Online
2021-05-31
DOI
10.3390/antibiotics10060652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol
- (2021) Yasaman Taheri et al. Frontiers in Pharmacology
- Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study
- (2021) Jia-Yih Feng et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
- (2021) Katie A Parsels et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
- (2021) Alexandre Bleibtreu et al. Microorganisms
- The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
- (2021) Beata Kowalska-Krochmal et al. Pathogens
- The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation
- (2021) Aurelia H.M. de Vries Schultink et al. CLINICAL MICROBIOLOGY AND INFECTION
- The place in therapy of ceftazidime/avibactam and ceftolozane/tazobactam in hematological patients with febrile neutropenia
- (2021) Daniela Clerici et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Incidence of Infections and Predictors of Mortality during Checkpoint Inhibitors Immunotherapy in Patients with Advanced Lung Cancer: A Retrospective Cohort Study
- (2021) Davide Fiore Bavaro et al. Open Forum Infectious Diseases
- Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
- (2020) J. J. Rouby et al. INTENSIVE CARE MEDICINE
- Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
- (2020) Wei-min Zhu et al. Antimicrobial Resistance and Infection Control
- Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli
- (2020) Wenhui Chen et al. Annals of Translational Medicine
- Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales
- (2020) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Targeted therapies for autoimmune/idiopathic non-malignant diseases: risk and management of opportunistic infections
- (2020) Davide Fiore Bavaro et al. Expert Opinion On Drug Safety
- Cefiderocol for extensively-drug resistant gram-negative bacterial infections: real-world experience from a case-series and review of the literature
- (2020) Sandra Zingg et al. Open Forum Infectious Diseases
- Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug resistant Stenotrophomonas maltophilia
- (2020) M Biagi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
- (2020) Laura Alagna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of PK/PD–based strategies to preserve new molecules against multi-drug resistant gram-negative strains
- (2020) Chiara Adembri et al. JOURNAL OF CHEMOTHERAPY
- Cefiderocol Antimicrobial Susceptibility Testing Considerations: The Achilles Heel of the Trojan Horse?
- (2020) Patricia J. Simner et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients
- (2020) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively- and pan-resistant Acinetobacter baumannii
- (2020) A. Oliva et al. Journal of Global Antimicrobial Resistance
- Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: Impact of MDR and XDR bacteria
- (2020) Antonella Santoro et al. Open Forum Infectious Diseases
- Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting—Focus on ICU Patients and Gram-Negative Strains
- (2020) Chiara Adembri et al. Antibiotics-Basel
- Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study
- (2020) Alessandro Russo et al. Infectious Diseases and Therapy
- Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review
- (2020) Davide Fiore Bavaro et al. Infectious Diseases
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
- (2019) Xingran Du et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Lilian M. Abbo et al. CLINICAL TRANSPLANTATION
- Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
- (2019) Shio-Shin Jean et al. Expert Review of Anti-Infective Therapy
- Molecular mechanisms related to colistin resistance in Enterobacteriaceae
- (2019) Zahra Aghapour et al. Infection and Drug Resistance
- In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models
- (2019) Rio Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features
- (2019) Helena Ferreira Leal et al. BMC INFECTIOUS DISEASES
- Co-Infections of Two Strains of NDM-1 and OXA-232 Co-producing Klebsiella pneumoniae in a Kidney Transplant Patient
- (2019) Deisy A. Contreras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Compassionate use of cefiderocol in the treatment of an intraabdominal infection due to multidrug resistant Pseudomonas aeruginosa : A case report
- (2019) Ryan W. Stevens et al. PHARMACOTHERAPY
- Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
- (2019) Takafumi Sato et al. CLINICAL INFECTIOUS DISEASES
- The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
- (2019) Malcom G P Page CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin
- (2019) Takayuki Katsube et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
- (2019) Robert A Bonomo CLINICAL INFECTIOUS DISEASES
- Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis
- (2019) Adrian Schmid et al. Scientific Reports
- Impact of Baseline Characteristics on Future Episodes of Bloodstream Infections: Multistate Model in Septic Patients With Bloodstream Infections
- (2019) M Cristina Vazquez Guillamet et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction
- (2019) Anthony R. M. Coates et al. Expert Review of Anti-Infective Therapy
- Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance
- (2019) Eleonora Bunsow et al. JOURNAL OF INFECTION
- The last breath for inhaled antibiotics and VAP? Not so fast
- (2019) Daniel A Sweeney et al. LANCET INFECTIOUS DISEASES
- Secular Trends in Infection-Related Mortality after Kidney Transplantation
- (2018) Susanna Kinnunen et al. Clinical Journal of the American Society of Nephrology
- The Surviving Sepsis Campaign Bundle: 2018 update
- (2018) Mitchell M. Levy et al. INTENSIVE CARE MEDICINE
- Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance
- (2018) Carolina Garcia-Vidal et al. PLoS One
- Increasing evidence of potential toxicity of a common antibiotic combination
- (2018) Morgan Scully et al. Journal of Infection and Public Health
- Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients
- (2018) Michele Bartoletti et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
- (2018) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
- (2017) Antoni Torres et al. EUROPEAN RESPIRATORY JOURNAL
- Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
- (2017) Justin R. Lenhard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and bla NDM-5 : Preparation for a Postantibiotic Era
- (2017) Zackery P. Bulman et al. mBio
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013
- (2015) Sibylle H. Lob et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections
- (2015) Borna Mehrad et al. CHEST
- Colistin, mechanisms and prevalence of resistance
- (2015) Abed Zahedi Bialvaei et al. CURRENT MEDICAL RESEARCH AND OPINION
- Why is Acinetobacter baumannii a problem for critically ill patients?
- (2015) Marin H. Kollef et al. INTENSIVE CARE MEDICINE
- Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study
- (2015) Simone Lanini et al. PLoS One
- Prediction of resistance development against drug combinations by collateral responses to component drugs
- (2014) C. Munck et al. Science Translational Medicine
- Pharmacokinetic and Pharmacodynamic Issues for Antimicrobial Therapy in Patients With Cancer
- (2012) U. Theuretzbacher CLINICAL INFECTIOUS DISEASES
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination therapies for combating antimicrobial resistance
- (2011) Michael A Fischbach CURRENT OPINION IN MICROBIOLOGY
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started